Patent ID: 11890264
Assignee: UNIVERSITATS-KINDERSPITAL BEIDER BASEL
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treatment or prevention of migraine and/or symptoms thereof in a patient in need thereof, said method comprising administering to the patient a compound which is a metabolic precursor of βHB selected from the group consisting of
(i) a pharmaceutically acceptable ester of beta-hydroxybutyrate (βHB),
(ii) a pharmaceutically acceptable ester of acetoacetate (AcAc),
(iii) a compound comprising an acetoacetyl- or 3-hydroxybutyrate moiety,
(iv) a keto ester,
(v) a middle chain triglyceride (MCT), and
(vi) a pharmaceutically acceptable salt of any one of (i) to (v).